O
22
2
STX
56
4
CB
51
3
FTI
76
3
BSX
70
2
TROW
51
3
APH
67
3
URBN
42
4
HPE
61
6
MTB
65
2
TMO
47
3
LMT
32
-12
JWN
42
2
DOW
34
4
AIG
44
6
INTU
54
3
COP
54
-2
PGR
63
3
JPM
67
4
SWK
61
5
O
22
2
STX
56
4
CB
51
3
FTI
76
3
BSX
70
2
TROW
51
3
APH
67
3
URBN
42
4
HPE
61
6
MTB
65
2
TMO
47
3
LMT
32
-12
JWN
42
2
DOW
34
4
AIG
44
6
INTU
54
3
COP
54
-2
PGR
63
3
JPM
67
4
SWK
61
5
Financhill
Back

Biodexa Pharmaceuticals PLC Vs. Target Industry Stock Comparison

Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
4.36
Seasonality Move:
-24.92%
Sell
20

TGT
Target

Last Price:
121.59
Seasonality Move:
4.08%
Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals PLC [BDRX] share price is $4.40. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $121.59. The Score for TGT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals PLC's stock price today?

  • The Biodexa Pharmaceuticals PLC share price today is $4.40
    The current trend is relatively stagnant and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $121.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing slight selling pressure.

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 39.46 Sell
Chaikin Money Flow: -5027537 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.46 - 6.44) Sell
Bollinger Bands (100): (-0.1 - 4.74) Buy

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.85 Sell
Relative Strength Index (14 RSI): 23.91 Sell
Chaikin Money Flow: -8404826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (140.56 - 157.62) Sell
Bollinger Bands (100): (142.35 - 156.95) Sell

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.23 Buy
20-day SMA: 5.23 Sell
50-day SMA: 3.96 Buy
200-day SMA: 1.73 Buy
8-day EMA: 4.29 Buy
20-day EMA: 4.75 Sell
50-day EMA: 4.1 Buy
200-day EMA: 12.21 Sell

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 146.51 Sell
20-day SMA: 148.61 Sell
50-day SMA: 151.64 Sell
200-day SMA: 153.85 Sell
8-day EMA: 141.24 Sell
20-day EMA: 147.16 Sell
50-day EMA: 149.8 Sell
200-day EMA: 149.63 Sell

Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.38 per share.

Biodexa Pharmaceuticals PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):